跳至主要内容
临床试验/NCT03483142
NCT03483142Unknown3 期

the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation

ahmed nagy shaker ramadan1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
50
试验地点
1
主要终点
blood loss

研究概览

简要总结

assess the effect of using misoprostol in abdominal myomectomy operations on blood loss, duration of the operation and possible operative complications. Research question Does pre-operative misoprostol affect on intra-operative blood loss during and after myomectomy operation ?. Research hypothesis Pre-operative misoprostol may reduce intra-operative blood loss during and after myomectomy operation .

详细描述

. Type of Study : Prospective double blind randomized placebo controlled clinical trial.

  • Study Setting : This study will be conducted in Ain Shams University Maternity hospital.
  • Study Period : 6 months
  • Study Population : Patients will be recruited in this study those attending gynecology ward at Ain Shams University Maternity hospital who are 25-50 years old with symptomatic uterine myoma

Methodology

All women will be subjected to:

History taking:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Premenopausal patients aged between 35 to 50 years old.
  • Five or less symptomatic uterine myomas .
  • Maximum diameter of the largest myoma is 6 cm .
  • All myomas are subserous or intramural.
  • Uterine size less than 24 weeks pregnancy

排除标准

  • History of previous surgery.
  • Allergy to Misoprostol.
  • Hypertension.
  • Cardiac and Pulmonary diseases.
  • Patients who have bleeding disorders.
  • Anemia (Hb < 10g %).
  • Chronic endocrine or metabolic diseases such as Diabetes.
  • Obesity (body mass index > 30 kg/m2).
  • Cases that will require intraoperative conversion of myomectomy to hysterectomy.

研究组 & 干预措施

misoprostol group

Experimental

misoprostol group ( study group ) ( 25 patient): who will receive 400 microgram (tablet 200mcg X 2) misoprostol rectally one hour before operation

干预措施: Misoprostol (Drug)

placebo group

Placebo Comparator

( 25 patient): who will receive placebo . two rectal placebo tablet of the same size and shape as the misoprostol.

干预措施: Placebos (Drug)

结局指标

主要结局

blood loss

时间窗: time of operation

reduce intra operative blood loss during myomectomy

次要结局

未报告次要终点

研究者

发起方
ahmed nagy shaker ramadan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

ahmed nagy shaker ramadan

resident of obstetric and gynecology

Ain Shams Maternity Hospital

研究点 (1)

Loading locations...

相似试验